Determination of Tacrolimus Concentration and Protein Expression of P-glycoprotein in Single Human Renal Core Biopsies

Abstract

Abstract Tacrolimus is currently the cornerstone of immunosuppressive protocols for renal transplant recipients. Despite therapeutic whole blood monitoring, tacrolimus is associated with nephrotoxicity and it has been hypothesized that intrarenal accumulation of tacrolimus and/or its metabolites are involved. As tacrolimus is a substrate of P-glycoprotein (P-gp), the expression and activity of this efflux transporter could influence the levels of tacrolimus in renal tissue. The primary aim of this study was to develop and validate a method for quantification of tacrolimus in tissue homogenates from single human renal core biopsies. The secondary aim was to provide measures of P-gp expression and of the demethylated metabolites of tacrolimus in the same renal biopsy. Human renal tissue, with and without clinical tacrolimus exposure, was used for method development and validation. Homogenates were prepared with bead-beating, and concentrations of tacrolimus and its demethylated metabolites were analyzed with liquid chromatography tandem mass spectrometry after protein precipitation. A Western blot method was used for semi-quantification of P-gp expression in the homogenates. The final methods were applied to renal core biopsies from two transplant patients. The tacrolimus assay showed within- and between-run mean accuracy between 99.7 % and 107 % and coefficients of variation ≤6.7 %. Matrix effects were non-significant and samples were stable for three months pre-analytically when stored at -80 °C. Tacrolimus concentrations in the renal core biopsies were 62.6 and 43.7 pg/mg tissue. The methods for measurement of desmethyl-tacrolimus and P-gp expression were suitable for semi-quantification in homogenates from renal core biopsies. These methods may be valuable for the elucidation of the pharmacokinetic mechanisms behind tacrolimus-induced nephrotoxicity in renal transplant recipients.